Archives of Dermatological Research

, Volume 308, Issue 4, pp 277–281 | Cite as

Hashimoto’s thyroiditis could be secondary to vitiligo: the possibility of antigen crossover and oxidative stress between the two diseases

  • Qingli Gong
  • Xue Li
  • Qixing Gong
  • Wenyuan Zhu
  • Guoxin Song
  • Yan LuEmail author
Concise Communication


Autoimmune thyroid diseases (AITDs) are often accompanied by vitiligo, and the sera of patients with vitiligo often demonstrate increased frequencies of thyroid autoantibodies. In this study, we investigated the expression of melanocyte-associated antigens in tissues from patients with Hashimoto’s thyroiditis (HT) without vitiligo using immunohistochemistry. Tissues of HT without vitiligo, as well as normal thyroid tissues, were both negative for the expression of NKI/beteb, gp100, tyrosinase-related protein 1 (TRP1), HMB-45 and S100, whereas they were positive for the expression of tyrosinase-related protein 2 (TRP2), lysosome-associated membrane protein 1 (LAMP1) and CD69. Tyrosinase (TYR) was only detected in tissues of HT, and levels of LAMP1 and CD69 were higher in tissues of HT than in normal thyroid tissues (p < 0.005). These results suggest the possibility of antigen crossover and oxidative stress between vitiligo and HT that might represent an immunological basis for secondary HT associated with vitiligo.


Hashimoto’s thyroiditis Immunohistochemistry Melanocytes Oxidative stress Vitiligo 



This study was supported by the National Natural Science Foundation of China (Grant No. 81171517).

Compliance with ethical standards

Conflict of interest



  1. 1.
    Colucci R, Lotti F, Dragoni F, Arunachalam M, Lotti T, Benvenga S, Moretti S (2014) High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. Br J Dermatol 171:786–798CrossRefPubMedGoogle Scholar
  2. 2.
    Fishman P, Merimski O, Baharav E, Shoenfeld Y (1997) Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo. Cancer 79:1461–1464CrossRefPubMedGoogle Scholar
  3. 3.
    Iacovelli P, Sinagra JL, Vidolin AP, Marenda S, Capitanio B, Leone G, Picardo M (2005) Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology 210:26–30CrossRefPubMedGoogle Scholar
  4. 4.
    Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP (1997) Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol 109:495–500CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP (1998) Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA). Clin Exp Immunol 114:333–338CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP (1998) Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Br J Dermatol 39:798–805CrossRefGoogle Scholar
  7. 7.
    Lassoued S, Mseddi M, Mnif F, Abid M, Guermazi F, Masmoudi H, El Feki A, Attia H (2010) A comparative study of the oxidative profile in Graves’ disease, Hashimoto’s thyroiditis, and papillary thyroid cancer. Biol Trace Elem Res 138:107–115CrossRefPubMedGoogle Scholar
  8. 8.
    Namazi MR (2007) Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: could they be interconnected? Pigment Cell Res 20:360–363CrossRefPubMedGoogle Scholar
  9. 9.
    Taieb A, Alomar A, Böhm M, Dell’anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, Leone G, Moretti S, Nieuweboer-Krobotova L, Olsson MJ, Parsad D, Passeron T, Tanew A, van der Veen W, van Geel N, Whitton M, Wolkerstorfer A, Picardo M, Vitiligo European Task Force (VETF), European Academy of Dermatology and Venereology (EADV), Union Europe´enne des Me´decins Spe´cialistes (UEMS) (2013) Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol 168:5–19CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Qingli Gong
    • 1
  • Xue Li
    • 1
  • Qixing Gong
    • 2
  • Wenyuan Zhu
    • 1
  • Guoxin Song
    • 2
  • Yan Lu
    • 1
    Email author
  1. 1.Department of DermatologyThe First Affiliated Hospital of Nanjing Medical UniversityNanjingPeople’s Republic of China
  2. 2.Department of PathologyThe First Affiliated Hospital of Nanjing Medical UniversityNanjingPeople’s Republic of China

Personalised recommendations